http://www.ncbi.nlm.nih.gov/pubmed/23359310
CONCLUSION:
The preliminary evidence continues to show that
low-dose naltrexone has a specific and clinically beneficial impact on
fibromyalgia pain. The medication is widely available, inexpensive,
safe, and well-tolerated. Parallel-group randomized controlled trials
are needed to fully determine the efficacy of the medication.
No comments:
Post a Comment